Pure Global

A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction - Trial NCT06333028

Access comprehensive clinical trial information for NCT06333028 through Pure Global AI's free database. This phase not specified trial is sponsored by Bausch & Lomb Incorporated and is currently Not yet recruiting. The study focuses on Cataract. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06333028
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06333028
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction.

Study Focus

Cataract

enVista Aspire EA IOLs

Observational

device

Sponsor & Location

Bausch & Lomb Incorporated

Dover,Woodland Park,Garden City,Charleston,Sugar Land,Mount Pleasant, United States of America

Timeline & Enrollment

N/A

Jun 01, 2024

Sep 01, 2024

100 participants

Primary Outcome

Mean binocular BCDVA (logMAR) at Visit 1

Summary

A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract
 Extraction

ICD-10 Classifications

Other cataract
Cataract, unspecified
Complicated cataract
Other specified cataract
Senile cataract

Data Source

ClinicalTrials.gov

NCT06333028

Device Trial